vet-platform
(2)
KaliVir Immunotherapeutics
KaliVir Immunotherapeutics is a clinical-stage biotech developing next-generation oncolytic viral immunotherapies for cancer. Its proprietary Vaccinia Enhanced Template (VET) platform engineers vaccinia viruses that can be delivered intravenously, replicate selectively in tumors, and express therapeutic payloads that reshape the tumor microenvironment. Founded in 2019 and headquartered in Pittsburgh, the company advances an internal lead candidate, VET3-TGI, alongside partnered programs licensed to Astellas Pharma and Roche.
Koala Health
Koala Health is a Boston-based digital pet pharmacy built by alumni of PillPack (acquired by Amazon). It packages and delivers chronic pet medications organized by date and time, connecting pet parents directly with their veterinarians through a mobile-first experience. The platform reaches 80+ million pet owners across all 50 states and integrates with more than 25,000 independent veterinary clinics.